Table 1. Characteristics of the studies included in the meta-analysis.
Study | Year | Nationality | Ethnicity | Cancer types | No. of case/control | Source of control | Genotyping method |
---|---|---|---|---|---|---|---|
Brockmöller [10] | 1996 | German | Caucasian | BLC | 355/340 | Hospital | PCR-RFLP |
Tsuneoka [11] | 1996 | Japanese | Asian | HCC, LC | 30/64 | Population | PCR-RFLP |
Wadelius [12] | 1999 | Swedish, Danish | Caucasian | PC | 178/160 | Population | PCR-RFLP |
Chau [13] | 2000 | Japanese | Asian | HCC | 29/186 | Population | PCR-RFLP |
Roddam [14] | 2000 | British | Caucasian | Leukaemia | 557/952 | Population | Taqman |
Sachse [15] | 2002 | British | Caucasian | CRC | 490/592 | Population | PCR-RFLP |
Shi [16] | 2004 | Chinese | Asian | EC, GC, LC BLC | 607/372 | Population | PCR-RFLP |
Mochizuki [17] | 2005 | Japanese | Asian | HCC | 44/843 | Population | PCR-RFLP |
Sugimoto [18] | 2005 | Japanese | Asian | GC | 111/315 | Hospital | PCR-RFLP |
Landi [19] | 2005 | Spanish | Caucasian | CRC | 351/321 | Population | APEX |
Zhou [20] | 2006 | Chinese | Asian | EC | 127/254 | Hospital | PCR-RFLP |
Tamer [21] | 2006 | Turkish | Caucasian | CRC, GC | 182/105 | Hospital | RT-PCR |
Xing [22] | 2006 | Chinese | Asian | BLC | 108/112 | Hospital | PCR-RFLP |
Gemignani [23] | 2007 | European | Caucasian | LC | 245/275 | Hospital | Microarray |
Jiang [24] | 2008 | Chinese | Asian | HCC | 48/88 | Hospital | PCR-RFLP |
Yang [25] | 2008 | Chinese | Asian | CRC | 83/112 | Hospital | PCR-RFLP |
Gra [26] | 2008 | Russian | Caucasian | Leukemia | 83/177 | Population | Microarray |
Yadav [7] | 2008 | Indian | Asian | HNC | 300/300 | Hospital | PCR-RFLP |
Khedhaier [27] | 2008 | Tunisian | Caucasian | BRC | 304/240 | Population | PCR-RFLP |
Sameer [28] | 2009 | Palestinian | Caucasian | Leukaemia | 52/200 | Population | PCR-RFLP |
Justenhoven [29] | 2009 | German | Caucasian | BC | 969/991 | Population | MassARRAY |
Zhang [30] | 2009 | Chinese | Asian | EC | 46/38 | Hospital | PCR-RFLP |
Wen [31] | 2009 | Chinese | Asian | BLC | 87/298 | Hospital | Taqman |
Isomura [3] | 2010 | Japanese | Asian | BTC | 65/566 | Hospital | PCR-RFLP |
Chang-Claude [4] | 2010 | German | Caucasian | BC | 3131/5478 | Population | MassARRAY |
Chang [32] | 2010 | Chinese | Asian | HCC | 68/254 | Population | Allele-specific PCR |
Gan [33] | 2011 | Chinese | Asian | BC | 600/600 | Population | PCR-RFLP |
Sainz [34] | 2011 | German | Caucasian | CRC | 1759/1776 | Population | SNPlex |
Feng [35] | 2011 | Chinese | Asian | HNC | 300/300 | Hospital | PCR-RFLP |
Unpublished data | / | Chinese | Asian | HCC, CRC | 245/283 | Hospital | PCR-RFLP |
CRC: colorectal cancer; LC: lung cancer; BC: breast cancer; BLC: bladder cancer; EC: esophagus cancer; HCC: hepatocellular carcinoma; GC: gastric cancer; PC: prostate cancer; BTC; biliary tract cancer; HNC: head neck cancer